Global markets live: Vodafone, Iliad, Unilever, KKR, Tesla...

01/24/2022 | 11:03am

Every day, the MarketScreener team selects the most important news about listed companies across the world.

 

 

 

  • Orange could appoint Christel Heydemann as CEO next Friday.
  • Renault, Nissan and Mitsubishi will unveil a new electric plan.
  • Vodafone and Iliad are discussing a merger in Italy.
  • Deutsche Lufthansa is said to be on the verge of acquiring 40% of ITA, the future Alitalia.
  • Activist fund Trian is taking a stake in Unilever, reports the Financial Times.
  • Kohl's has a $9 billion ($64 a share) buyout offer on the table from Starboard. Sycamore Partners is also said to be in the running, according to Bloomberg.
  • Temasek will buy Bridgepoint's UK testing business for $7bn.
  • KKR offers to buy Accell at EUR 58 per share.
  • AdvancedAdvT improves its bid for M&C Saatchi.
  • Blackwell Capital wants to get rid of Peloton Interactive's boss.
  • Commerzbank reveals that its Q4 2021 net profit will be cut by EUR 436m, due to provisions related to foreign currency loans in Poland.
  • In addition to looking at a deal with Iliad in Italy, Vodafone is also reportedly considering a takeover of 3 UK.
  • Mowi is offering to buy NTS at NOK 110 per share.
  • Pietro Labriola takes over Telecom Italia.
  • Fintech Chime is preparing an IPO with Goldman Sachs.
  • Tesla - Japan's Panasonic Group will start production of its new lithium-ion batteries for Tesla early next year and plans to invest about 80 billion yen in production facilities in Japan, the Nikkei daily reported Monday.
  • JPMorgan - The U.S. bank announced Monday that it has consolidated the bulk of its European operations into a single entity based in Germany to make them more competitive in the wake of Brexit.
  • Goldman Sachs- The U.S. bank promoted Luke Sarsfield to head its $1.7 trillion asset management division, Bloomberg reported Sunday.
  • Pfizer, BioNTech - People over age 60 who received four doses of the COVID-19 vaccine developed by Pfizer and BioNtech have three times the resistance against severe forms of the disease than the same age group who received only three doses, according to an Israeli study presented Sunday. Meanwhile, Pfizer CEO Albert Bourla said Saturday that an annual COVID-19 vaccine would be preferable to more frequent boosters in the fight against the pandemic

Major earnings releases: International Business Machine, Saudi Basic Industries, Philips, Halliburton, Computacenter, Nacon, Lumibird...

 

© MarketScreener.com 2022
Copier lien
Latest news about ""
6h ago
1d ago
2d ago
2d ago
3d ago